Play

In this episode, we’re featuring a presentation from the 2024 SHINE Conference: Why SOGI Matters, if You’re Not Counted, You Don’t Count, featuring Paula Niera, JD, MSN, RN, CEN, FAAN, Program Director, Office of Integrated Healthcare Delivery. Her talk focuses …

Episode 82: Why SOGI Matters| Johns Hopkins Center for Nursing Inquiry Read more »

Play

Pancreas cancer is associated with a very poor prognosis, with many people diagnosed with the disease given only months or a couple of years of predicted life remaining. Now an AI model may discern who is at risk to develop …

An AI model may help predict who is more likely to develop pancreas cancer, Elizabeth Tracey reports Read more »

Play

In trying to discern factors that may account for colorectal cancer incidence in younger people many diet and lifestyle factors fell short, a new study finds. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, points toward insulin …

Will GLP1 drugs tease out the relationship between insulin and cancer? Elizabeth Tracey reports Read more »

Play

A new, comprehensive study takes a look at lifestyle factors and colorectal cancer in younger people and fails to find a relationship. Kimmel Cancer Center director William Nelson at Johns Hopkins says he thinks it may be more subtle and …

Is there a relationship between diet, obesity and colorectal cancer? Elizabeth Tracey reports Read more »

Play

A comprehensive look at lifestyle factors and cancer rates among both older and younger people has left many people scratching their heads. The UK study examined a range of exposures and lifestyle factors trying to elucidate relationships, especially those that …

What accounts for increases in colorectal cancer among younger people? Elizabeth Tracey reports Read more »

Play

Daraxonrasib is the name of a drug for pancreas cancer that almost doubled survival for people with the disease in a clinical trial. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, says while the drug is going …

A new drug for pancreas cancer may be a game changer, Elizabeth Tracey reports Read more »

Play

Daraxonrasib is the name of a drug to treat pancreas cancer that has extended survival in many with the disease, a just reported clinical trial finds.  Johns Hopkins Kimmel Cancer Center director William Nelson says it’s gotten many people who treat …

A new drug for pancreas cancer may be a game changer, Elizabeth Tracey reports Read more »